DK1201246T3 - Anvendelse af trombopoietin som et medikament til behandling og forebyggelse af trombocytopeni - Google Patents

Anvendelse af trombopoietin som et medikament til behandling og forebyggelse af trombocytopeni

Info

Publication number
DK1201246T3
DK1201246T3 DK01123002T DK01123002T DK1201246T3 DK 1201246 T3 DK1201246 T3 DK 1201246T3 DK 01123002 T DK01123002 T DK 01123002T DK 01123002 T DK01123002 T DK 01123002T DK 1201246 T3 DK1201246 T3 DK 1201246T3
Authority
DK
Denmark
Prior art keywords
thrombopoietin
thrombocytopenia
treatment
low
materials
Prior art date
Application number
DK01123002T
Other languages
English (en)
Inventor
Griffith R Thomas
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1201246T3 publication Critical patent/DK1201246T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01123002T 1996-01-25 1997-01-13 Anvendelse af trombopoietin som et medikament til behandling og forebyggelse af trombocytopeni DK1201246T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US59192596A 1996-01-25 1996-01-25
US64144396A 1996-04-29 1996-04-29
US08/697,631 US5879673A (en) 1996-01-25 1996-08-28 Administration of thrombopoietin on a single day only
PCT/US1997/000438 WO1997026907A1 (en) 1996-01-25 1997-01-13 Novel administration of thrombopoietin

Publications (1)

Publication Number Publication Date
DK1201246T3 true DK1201246T3 (da) 2009-02-23

Family

ID=27416624

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01123002T DK1201246T3 (da) 1996-01-25 1997-01-13 Anvendelse af trombopoietin som et medikament til behandling og forebyggelse af trombocytopeni
DK97901434T DK0876152T3 (da) 1996-01-25 1997-01-13 Hidtil ukendt administrering af thrombopoietin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK97901434T DK0876152T3 (da) 1996-01-25 1997-01-13 Hidtil ukendt administrering af thrombopoietin

Country Status (11)

Country Link
US (1) US5879673A (da)
EP (2) EP1201246B1 (da)
JP (1) JP2000504325A (da)
AT (2) ATE216257T1 (da)
AU (1) AU711639B2 (da)
CA (1) CA2242417A1 (da)
DE (2) DE69712036T2 (da)
DK (2) DK1201246T3 (da)
ES (2) ES2175333T3 (da)
PT (1) PT876152E (da)
WO (1) WO1997026907A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4344697A (en) * 1996-10-04 1998-04-24 Amgen, Inc. Pharmaceutical compositions containing an mpl ligand
AU7589898A (en) * 1997-05-21 1998-12-11 Genentech Inc. Novel administration of thrombopoietin
AU2006201129B2 (en) * 1997-05-21 2008-03-13 Genentech, Inc. Novel administration of thrombopoietin
AU9265698A (en) * 1997-09-02 1999-03-22 Boehringer Mannheim Gmbh Mpl-receptor ligands, process for their preparation, medicaments containing themand their use for the treatment and prevention of thrombocytopaenia and anaemia
US6776984B1 (en) 1999-08-20 2004-08-17 George R. Schwartz Induced regeneration and repair of damaged neurons and nerve axon myelin
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
DE19956156A1 (de) * 1999-11-23 2001-06-13 Univ Eberhard Karls Verfahren zur Aufbereitung eines Präparates von Thrombozyten und Thrombozytenpräparat
US6871171B1 (en) * 2000-10-19 2005-03-22 Optimata Ltd. System and methods for optimized drug delivery and progression of diseased and normal cells
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides
JP2005505494A (ja) * 2001-02-23 2005-02-24 イミュネックス・コーポレーション 活性タンパク質の回収増加
DE10227606B3 (de) * 2002-06-20 2004-01-22 Bionethos Holding Gmbh Verwendung von Thrombopoietin zur Kultivierung von Hepatozyten
US20040028661A1 (en) * 2002-08-07 2004-02-12 Bartelmez Stephen H. Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
WO2005000891A2 (en) * 2003-06-26 2005-01-06 Merck Patent Gmbh Thrombopoietin proteins with improved properties
AU2003271194A1 (en) * 2003-10-09 2005-04-21 Daewoong Co., Ltd. Process for purifying human thrombopoietin with high content of sialic acid
AU2004309083B2 (en) 2003-12-30 2010-11-11 Augustinus Bader Tissue regeneration method
US7879318B2 (en) * 2006-01-23 2011-02-01 Mcw Research Foundation, Inc. Method of reducing the effects of ischemia by administration of a thrombopoietin receptor ligand
US20150031623A1 (en) * 2011-09-29 2015-01-29 Mcw Research Foundation, Inc. Thrombopoietin receptor ligands for neuroprotection
CN102973922B (zh) * 2012-12-18 2016-02-03 华东理工大学 一种融合蛋白的应用
JP6050289B2 (ja) * 2013-07-11 2016-12-21 Ｊｃｒファーマ株式会社 組換え蛋白質高発現細胞株の選択法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3560609B2 (ja) * 1992-11-13 2004-09-02 イミュネックス・コーポレーション Ｅｌｋリガンドと呼ばれる新規なサイトカイン
US5578301A (en) * 1993-12-14 1996-11-26 Sandoz Ltd. Method for using GM-CSF to reduce the acute phase response in a patient being administered IL-6 therapy
SG47030A1 (en) * 1994-01-03 1998-03-20 Genentech Inc Thrombopoietin
CN1229385C (zh) * 1994-03-31 2005-11-30 安姆根有限公司 刺激巨核细胞生长和分化的组合物及方法
US5593666A (en) * 1994-08-16 1997-01-14 The University Of Tennessee Research Corp. Methods and compositions for treating thrombocytopenia
US6013067A (en) * 1995-06-07 2000-01-11 Zymogenetics, Inc. Methods for increasing hematopoietic cells

Also Published As

Publication number Publication date
WO1997026907A1 (en) 1997-07-31
CA2242417A1 (en) 1997-07-31
DK0876152T3 (da) 2002-08-12
DE69712036D1 (de) 2002-05-23
ATE411039T1 (de) 2008-10-15
AU711639B2 (en) 1999-10-21
ATE216257T1 (de) 2002-05-15
PT876152E (pt) 2002-09-30
EP0876152A1 (en) 1998-11-11
US5879673A (en) 1999-03-09
EP1201246B1 (en) 2008-10-15
AU1533597A (en) 1997-08-20
ES2315255T3 (es) 2009-04-01
JP2000504325A (ja) 2000-04-11
DE69739050D1 (de) 2008-11-27
EP1201246A3 (en) 2002-05-08
EP1201246A2 (en) 2002-05-02
EP0876152B1 (en) 2002-04-17
DE69712036T2 (de) 2002-11-28
ES2175333T3 (es) 2002-11-16

Similar Documents

Publication Publication Date Title
DK1201246T3 (da) Anvendelse af trombopoietin som et medikament til behandling og forebyggelse af trombocytopeni
RU2004106569A (ru) Способ применения антибиотиков
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
RU95113492A (ru) Терапевтическая комбинация, содержащая человеческий интерферон, его применение, фармацевтический препарат, упаковка и способ лечения
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
NO306377B1 (no) Doseform for avgivelse av et medikament
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
YU61598A (sh) Tretmani bolesti uz korišćenje citokina
DE69803670D1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
ATE284696T1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
RU93050932A (ru) Средство для лечения атопического дерматита
DE69618511D1 (de) Gammainterferon enthaltende Zusammensetzung zur Prurigo-Behandlung
KR890007737A (ko) 진토작용을 하는 약제
KR930019207A (ko) 카르니틴 결핍 hiv-혈청양성 환자 치료용 l-카르니틴의 용도
KR890001558A (ko) 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염
RU95112605A (ru) Способ профилактики и лечения паразитарных и инфекционных болезней с использованием интерлейкина-1
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
RU98114485A (ru) Жаропонижающая композиция и способ лечения и профилактики гипертермии у человека
ATE328604T1 (de) Verwendung von wachstumshormon in niederen dosen
KR920700041A (ko) 치료화합물과 그의 조성 및 용도
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi